Author: Bobes J.
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.22, Iss.9, 2002-01, pp. : 609-622
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Tada Miho Shirakawa Kiyoharu Matsuoka Nobuya Mutoh Seitaro
Psychopharmacology, Vol. 176, Iss. 1, 2004-10 ,pp. :
Flunitrazepam/olanzapine/risperidone: Extrapyramidal symptoms: case report
Reactions Weekly, Vol. 1, Iss. 1432, 2012-01 ,pp. :
By Reimold M. Solbach C. Noda S. Schaefer J.-E. Bartels M. Beneke M. Machulla H.-J. Bares R. Glaser T. Wormstall H.
Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. :
Olanzapine and quetiapine: higher diabetes risk than risperidone
Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. :
Olanzapine/quetiapine/risperidone: Ischaemic priapism: case report
Reactions Weekly, Vol. 1, Iss. 1050, 2005-01 ,pp. :